EZH2 as a therapeutic target for multiple myeloma and other haematological malignancies-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

EZH2 as a therapeutic target for multiple myeloma and other haematological malignancies

Published:2018-12 Issue:1 Volume:6 Page:
ISSN:2050-7771
Container-title:Biomarker Research
language:en
Short-container-title:Biomark Res

Author:

Tremblay-LeMay Rosemarie,Rastgoo Nasrin,Pourabdollah Maryam,Chang Hong

Publisher

Springer Science and Business Media LLC

Subject

Biochemistry, medical,Clinical Biochemistry,Molecular Medicine

Link

http://link.springer.com/content/pdf/10.1186/s40364-018-0148-5.pdf

Reference46 articles.

1. Gan L, Yang Y, Li Q, Feng Y, Liu T, Guo W. Epigenetic regulation of cancer progression by EZH2: from biological insights to therapeutic potential. Biomark Res. 2018;6:10.

2. Wen Y, Cai J, Hou Y, Huang Z, Wang Z. Role of EZH2 in cancer stem cells: from biological insight to a therapeutic target. Oncotarget. 2017;8:37974–90.

3. Yan KS, Lin CY, Liao TW, et al. EZH2 in Cancer Progression and Potential Application in Cancer Therapy: A Friend or Foe?. Int J Mol Sci. 2017;18(6):1172. Published 2017 May 31. https://doi.org/10.3390/ijms18061172 .

4. Morin RD, Johnson NA, Severson TM, Mungall AJ, An J, Goya R, et al. Somatic mutations altering EZH2 (Tyr641) in follicular and diffuse large B-cell lymphomas of germinal-center origin. Nat Genet. 2010;42:181–5.

5. Ryan RJ, Nitta M, Borger D, Zukerberg LR, Ferry JA, Harris NL, et al. EZH2 codon 641 mutations are common in BCL2-rearranged germinal center B cell lymphomas. PLoS One. 2011;6:e28585.

Cited by 45 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Road Ahead in Pancreatic Cancer: Emerging Trends and Therapeutic Prospects;Biomedicines;2024-09-02

2. EZH2‐associated tumor malignancy: A prominent target for cancer treatment;Clinical Genetics;2024-06-17

3. EZH2 inhibition induces senescence via ERK1/2 signaling pathway in multiple myeloma;Acta Biochimica et Biophysica Sinica;2024-05-27

4. Ellagic acid: a potential inhibitor of enhancer of zeste homolog-2 and protein arginine methyltransferase-5;2024-05-23

5. Ferroptosis mechanisms and its novel potential therapeutic targets for DLBCL;Biomedicine & Pharmacotherapy;2024-04

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3